SynAct Pharma AB (OSTO:SYNACT) FFO


OSTO:SYNACT SynAct Pharma AB OSTO:SYNACT
18 GF Score
Price kr15.44
! 1 Warning Sign
View Full Analysis

What is SynAct Pharma AB FFO?

FFO (Funds from operations) only applies to REITs.

OSTO:SYNACT
18GF Score
SynAct Pharma AB OSTO:SYNACT
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SynAct Pharma AB Business Description

Other Exchanges 8F8:Germany
Address Scheelevagen 2, Lund, SWE, 223 63
SynAct Pharma AB is a clinical-stage biotechnology company focused on resolving inflammation through the selective activation of the melanocortin system. The company has a broad portfolio of oral and injectable selective melanocortin agonists aimed at inducing anti-inflammatory and inflammation-resolution activity to help patients achieve immune balance and overcome inflammation. AP1189, the company's drug candidate, is being evaluated in three Phase 2 clinical programs regarding rheumatoid arthritis, idiopathic membranous glomerulonephritis and virus-induced respiratory failure.
18GF Score

Get the complete analysis for OSTO:SYNACT

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr15.44
Price